First-line treatment of asymptomatic or mildly symptomatic metastatic castration-resistant prostate carcinoma

Jürgen E. Gschwend

doi:10.1159/000456165

First-line treatment of asymptomatic or mildly symptomatic metastatic castration-resistant prostate carcinoma

Jürgen E. Gschwend

Chair of Urology

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Translated title of the contribution	Erstlinientherapie des nicht oder mild symptomatischen metastasierten kastrationsresistenten Prostatakarzinoms
Original language	English
Pages (from-to)	4-5
Number of pages	2
Journal	Oncology Research and Treatment
Volume	40
Issue number	2
DOIs	https://doi.org/10.1159/000456165
State	Published - 1 Mar 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1159/000456165

Cite this

@article{a2f0d6215469481fb9b73948f8e019b0,

title = "First-line treatment of asymptomatic or mildly symptomatic metastatic castration-resistant prostate carcinoma",

author = "Gschwend, \{J{\"u}rgen E.\}",

year = "2017",

month = mar,

day = "1",

doi = "10.1159/000456165",

language = "English",

volume = "40",

pages = "4--5",

journal = "Oncology Research and Treatment",

issn = "2296-5270",

publisher = "S. Karger AG",

number = "2",

}

TY - JOUR

T1 - First-line treatment of asymptomatic or mildly symptomatic metastatic castration-resistant prostate carcinoma

AU - Gschwend, Jürgen E.

PY - 2017/3/1

Y1 - 2017/3/1

UR - https://www.scopus.com/pages/publications/85017120106

U2 - 10.1159/000456165

DO - 10.1159/000456165

M3 - Article

C2 - 28365707

AN - SCOPUS:85017120106

SN - 2296-5270

VL - 40

SP - 4

EP - 5

JO - Oncology Research and Treatment

JF - Oncology Research and Treatment

IS - 2

ER -

First-line treatment of asymptomatic or mildly symptomatic metastatic castration-resistant prostate carcinoma

UN SDGs

Access to Document

Other files and links

Cite this